Better Therapeutics, Inc. (BTTX) Social Stream
BETTER THERAPEUTICS INC (BTTX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering BETTER THERAPEUTICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-07-29 | 1 | $19 | $19 | $19 | $0.259 | 7235.91% |
| 2021-11-28 | 4 | $19 | $17 | $18 | $0.259 | 6849.81% |
| 2022-03-15 | 4 | $19 | $15 | $17 | $0.259 | 6463.71% |
| 2022-05-13 | 4 | $19 | $15 | $17.333 | $0.259 | 6592.28% |
| 2022-05-15 | 4 | $15 | $15 | $15 | $0.259 | 5691.51% |
| 2022-09-22 | 3 | $17 | $15 | $16 | $0.259 | 6077.61% |
| 2022-12-12 | 3 | $15 | $14 | $14.5 | $0.259 | 5498.46% |
| 2023-03-31 | 3 | $15 | $9 | $12 | $0.259 | 4533.2% |
| 2023-04-03 | 3 | $9 | $9 | $9 | $0.259 | 3374.9% |
| 2023-05-12 | 4 | $9 | $5 | $7 | $0.259 | 2602.7% |
| 2023-08-10 | 4 | $9 | $3 | $6 | $0.259 | 2216.6% |
The Trend in the Analyst Price Target
Over the past 17 months, BTTX's average price target has gone down $11.33.
BTTX reports an average of 945.17% for its upside potential over the past 132 days.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-04-03 | 3 | 9 | 9 | 9 | 0.712 | 1164.04% |
| 2023-04-14 | 4 | 9 | 5 | 7 | 1.320 | 430.3% |
| 2023-05-12 | 4 | 9 | 5 | 7 | 0.782 | 795.14% |
| 2023-08-10 | 3 | 9 | 3 | 6 | 0.728 | 724.18% |
| 2023-08-10 | 4 | 9 | 3 | 6 | 0.728 | 724.18% |
BTTX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.5 | 3 | 0 | 1 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
Over the past 153 days, BTTX's average broker recommendation rating improved by 0.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- BTTX has a greater upside potential (average analyst target price relative to current price) than 1792.88% of all US stocks.
- BTTX has a higher number of analysts covering the stock than 123.85% of Healthcare stocks.
- In terms of how BETTER THERAPEUTICS INC fares relative to Healthcare stocks, note that its variance in analysts' estimates is lower than -265.4% of that group.
- To contextualize these metrics, consider that out of Healthcare stocks, BETTER THERAPEUTICS INC's average analyst price target is greater than 433.49% of them.
Stocks similar to BETTER THERAPEUTICS INC in the Healthcare industry regarding analyst recommendations and price targets are MGRX, AMS, and MDXH.
View All Top Stocks by Price Target
What is the outlook for BTTX? Use POWR Ratings for clearer insight into price direction.